IPCA Laboratories Limited — Updates, 12-06-2026: Press Release
12-06-2026 | 05:31 pm
12-06-2026 | 05:31 pm
Ipca Labs partnered globally with Bhami's Research Lab for novel subcutaneous biologics delivery tech. This targets developing cancer and inflammatory disease treatments. Ipca handles development/commercialization; BRL gets technology transfer milestones and sales royalties.
No comments yet. Be the first to comment!
